🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Ertugliflozin 15 mg

Found 16 matching trials

A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)

PHASE3

This is a study to evaluate the efficacy and safety of the addition of ertu...

Status

Completed

Location

Multiple Locations

Start Date

2015-12-16

Trial ID

NCT02630706

Treatments Being Tested

Ertugliflozin 5 mg Ertugliflozin 15 mg Placebo matching ertugliflozin Metformin Glimepiride

Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)

PHASE3

This study will evaluate the efficacy and safety of the addition of ertugli...

Status

Completed

Location

Multiple Locations

Start Date

2013-12-16

Trial ID

NCT01999218

Treatments Being Tested

Ertugliflozin 5 mg Ertugliflozin 10 mg Glimerpiride Placebo to Ertugliflozin Placebo to Glimepiride Metformin Sitagliptin

Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)

PHASE3

This study evaluated the safety and efficacy of ertugliflozin (MK-8835) in ...

Status

Completed

Location

The University of Alabama at Birmingham ( Site 2207)

Start Date

2019-10-08

Trial ID

NCT04029480

Treatments Being Tested

Ertugliflozin 5 mg Ertugliflozin 15 mg Placebo to ertugliflozin 15 mg Placebo to ertugliflozin 5 mg Insulin Metformin

A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).

PHASE3

This is an efficacy and safety study of ertugliflozin in participants with ...

Status

Completed

Location

Multiple Locations

Start Date

2013-12-13

Trial ID

NCT02033889

Treatments Being Tested

Ertugliflozin 5 mg Ertugliflozin 15 mg Placebo to Ertugliflozin Glimepiride Placebo to Glimepiride Basal Insulin Metformin

A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)

PHASE3

This study will evaluate the efficacy and safety of ertugliflozin (MK-8835/...

Status

Completed

Location

Multiple Locations

Start Date

2013-12-02

Trial ID

NCT01986855

Treatments Being Tested

Ertugliflozin 5 mg Placebo 5 mg Ertugliflozin 10 mg Placebo 10 mg

A Phase 1 Study of Ertugliflozin in Healthy Male Participants (MK-8835-020)

PHASE1

This study will evaluate the absolute oral bioavailability (F) and fraction...

Status

Completed

Location

Multiple Locations

Start Date

2014-10-29

Trial ID

NCT02411929

Treatments Being Tested

Unlabeled ertugliflozin for oral use 14^C-labeled ertugliflozin for IV use 14^C-labeled ertugliflozin for oral use

Low-CArbohydrate Diet and SGLT2-INhibitOr to Achieve Moderate Ketosis in Healthy Volunteers

PHASE1

The purpose of this study is to help us better understand how plasma ketone...

Status

Active Not Recruiting

Location

AdventHealth Translational Research Institute

Start Date

2023-03-16

Trial ID

NCT05662865

Treatments Being Tested

SGLT2 inhibitor Controlled, Adaptive Study Diet

Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004)

PHASE3

An overall study of the cardiovascular outcomes following treatment with er...

Status

Completed

Location

Multiple Locations

Start Date

2013-11-04

Trial ID

NCT01986881

Treatments Being Tested

Ertugliflozin Placebo Glycemic Rescue

Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)

PHASE1

This is a study to evaluate the effect of renal impairment on the pharmacok...

Status

Completed

Location

Multiple Locations

Start Date

2013-10-01

Trial ID

NCT01948986

Treatments Being Tested

Ertugliflozin

DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study

PHASE4

SGLT2 inhibitors such as ertugliflozin improve blood pressure and kidney ou...

Status

Completed

Location

Amsterdam UMC

Start Date

2023-07-03

Trial ID

NCT05727579

Treatments Being Tested

Salt-Diet and/or Ertugliflozin Ertugliflozin 15 mg

Previous Next